Echocardiography Market Analysis 2026

Market dynamics of Echocardiography: 

Key drivers of the Echocardiography Market

• Growing Number of Heart-Related Conditions Will Increase Need for Echocardiography-

The prevalence of heart-related conditions, including pericardial disease, heart failure, heart valve disease, and arrhythmias, has been steadily increasing. This has a direct correlation with the standard of living in cities. This is combined with additional factors such as a diet heavy in cholesterol, trans fat, and saturated fat, as well as a lack of physical activity. An increase in sedentary behavior, which includes drinking and smoking, also tends to raise the risk of heart disease. Based on the CDC's 2022 estimates, around 805,000 Americans get a heart attack annually. 605,000 of these are first-time heart attack cases.
Source-http://https://www.health.ny.gov/diseases/cardiovascular/heart_disease/#:~:text=Heart%20Disease%20in%20the%20United%20States&text=Coronary%20heart%20disease%20(CHD)%20is,already%20had%20a%20heart%20attack. 

Cardiovascular disease is the cause of over half of all fatalities in Europe. For example, according to the National Library of Medicine, the predicted annual loss of life due to CVD in Europe in 2021 will be greater than 60.0 million years.
Source- https://pubmed.ncbi.nlm.nih.gov/34497402/ 

The risk of heat-related illnesses is increased by unhealthy lifestyle choices like smoking cigarettes and eating a diet high in cholesterol and unsaturated fat. According to a research report released by NCBI in July 2020, smoking was a contributing factor in 30.0% of cases of coronary heart disease. This finding led to a rise in angioplasty procedures, which in turn drove the market's expansion.
Source- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399440/ 

Since cardiac disorders are so common, the market is anticipated to increase at a large rate throughout the projected period.

• Device Adoption Worldwide is Being Driven by Benefits Over Other Cardiac Diagnostic Procedures-

In the process of diagnosing and treating heart-related conditions such as coronary artery disease, heart attacks, blood clots, and chest pain, medical professionals may advise cardiac catheterization and blood testing. These operations involve intrusions. A longer hospital stay is necessary for cardiac catheterization, and the procedure carries some risks, including bleeding, blood clots, arterial damage, heart attacks, and other adverse effects. These factors often lead to physicians using this method for cardiac diagnosis only in limited circumstances. Cardiovascular ultrasonography, magnetic resonance imaging (MRI), nuclear stress testing, and coronary computed tomography angiography (CTA) are further heart diagnostic modalities. Diagnostic non-invasive echocardiography is a process that offers details about the hemodynamics and operation of the heart. Following electrocardiography and a chest X-ray, it is the most often utilized cardiovascular diagnostic test. The British Society of Echocardiography reported a 5.7% annual rise in the demand for echocardiograms.
Source- https://committees.parliament.uk/writtenevidence/108668/pdf/ 

This test is the most often requested cardiovascular imaging examination, both inpatient and outpatient, and it is essential to the practice of critical care medicine, anesthesia, acute general medicine, cardiology, and general practice. Thus, hospitals and diagnostic centers have been using these gadgets more frequently lately. This can be explained by the fact that, in contrast to other diagnostic techniques that rely on radiation to get data, echocardiograms carry little to no danger. Furthermore, continuous monitoring of these heart disease diagnostics is beneficial for people who have already experienced heart failure. Echocardiograms are also utilized in routine nursing care for cancer patients who run the risk of cardiotoxicity.

Echo device acceptance has been fueled by these benefits and uses, which are anticipated to have a favorable effect on the market's growth over the forecast period.

• AFib in the geriatric population will cause high demand for Echocardiography Devices-

The risk of AFib increases with age. Patients who experience hypertension, obesity, diabetes, other cardiovascular disorders, and old age are also at risk for atrial fibrillation. In addition, older adults are more prone to suffer from various illnesses that increase their risk of AFib, such as elevated blood pressure, heart disease, issues with the heart valves, and heart attack. According to The Centers for Disease Control and Prevention, as people age, there is an increase in AFib instances.

Ablation Catheter treatment can help maintain a regular heartbeat if you have AFib. The geriatric population's increased incidence of atrial fibrillation, technological advancements, and a preference for catheter ablation as a cardiac arrhythmia therapy are driving the atrial fibrillation market's growth. As a result, it promotes market expansion. For instance, The Centers for Disease Control and Prevention estimate that in the United States, atrial fibrillation affects 2% of those under 65 and 9% of those over 65. By 2030, it is expected that the prevalence of atrial fibrillation will have doubled. 
Source- https://www.cdc.gov/heartdisease/atrial_fibrillation.htm 

For the leading companies in the atrial fibrillation devices market, this growing geriatric patient pool will consequently present numerous chances during the projected period.

Restraints of the Echocardiography Market

• Certain Obstacles Associated with Echocardiography Device Use May Restrict Their Adoption-

The market's ability to expand is constrained by the expensive price of Echo devices. Furthermore, portable cardiac ultrasonography equipment has significant restrictions. Despite their reduced size, they have a smaller screen, which could affect the diagnosis. With fewer ultrasonic frequencies and inadequate image optimization, the resolution is decreased. Moreover, they can only create 2d images. The need for echocardiography has grown, and as a result, wait times have gone up while worker capacity has decreased. In February 2020, 4% of patients in England were waiting more than six weeks for an echocardiography; by contrast, 7% of patients were waiting longer. There are currently 155,000 patients waiting in total for outpatient echocardiography, with 66,000 of those patients waiting more than six weeks.
Source- https://committees.parliament.uk/writtenevidence/108668/pdf/ 

As a result, in the upcoming years, their acceptance may be constrained by their large size and expensive price.

Opportunities in the Echocardiography Market

• Echocardiography Devices Using Al and Other Cutting-Edge Technologies to Support Market Growth-

One of the most significant and vital diagnostic procedures for the clinical diagnosis of cardiovascular disorders is echocardiography. To improve performance and maximize the potential of the diagnostic test, these gadgets have undergone continuous research and development. Big businesses frequently spend money on R&D to introduce new goods that use the newest technology available. The advancement of virtual reality technology facilitates the manipulation of echocardiography pictures in three dimensions, enabling clinicians to utilize this technology to plan treatments in advance. Healthcare experts are therefore becoming more and more in demand for Al integration, new point-of-care equipment, and pocket-sized cardiac ultrasound instruments. For example, Koninklijke Philips reduced the time required for manual techniques by half in December 2021 by introducing an Al-driven auto-measure application in its EPIQ Cx and Affiniti CVx ultrasound equipment. This allowed for speedy and reliable measurement delivery. Therefore, during the projected time, the introduction of such technical innovations by industry participants is anticipated to increase significantly the use of technologically advanced equipment.
Source- https://www.philips.com/a-w/about/news/archive/standard/news/press/2021/20211209-philips-introduces-fully-integrated-echocardiography-experience-bringing-together-new-transducer-technology-ai-driven-automated-measurements-and-remote-access-at-euroecho-2021.html  

Additionally, Philips Healthcare developed a new real-time 3D Intracardiac Echocardiography (ICE) device in July 2021. This gadget is used for minimally invasive cardiac surgery. The probe is inserted into the patient's esophagus and passed through the throat until it is in close proximity to the heart. General anesthesia is used for this surgery.
Source- https://www.philips.com/a-w/about/news/archive/standard/news/press/2021/20210701-philips-announces-first-patient-treated-with-its-new-real-time-3d-intracardiac-echocardiography-catheter-verisight-pro.html  

Impact of COVID-19 on the Echocardiography Market

During COVID-19, the market's growth rate decreased. The drop was caused by fewer individuals seeking treatment and diagnosis for cardiovascular disease in clinics and hospitals, as well as by delaying non-emergency treatments. Testing for cardiovascular diseases decreased significantly during this time because non-COVID-19-related diagnostic procedures were viewed as low-priority. For example, according to data released by the International Atomic Energy Agency (IAEA) in January 2021, the total number of cardiovascular diagnostic operations in 2020 was -64.0% lower than in the year before. Additionally, it was reported that within the same period, there was a global drop in stress tests of -78.0%, transesophageal cardiac ultrasound of 76.0%, and transthoracic echocardiograms of -59.0%.
Source- https://www.iaea.org/newscenter/pressreleases/covid-19-pandemic-causes-major-decrease-in-heart-disease-tests-iaea-survey-shows  

For instance, the sales of FUJIFILM Holdings Corporation were 2,315,141 million Yen in 2020, as compared to 2,431,489 million Yen in 2019.  The company's revenue growth was impacted by a decline in imaging solution sales, despite a rise in sales of medical systems.
Source- https://ir.fujifilm.com/en/investors/ir-news/auto_20200522421424/pdfFile.pdf 
 

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Echocardiography Market is witnessing significant growth in the near future.

In 2023, the Cart Based segment accounted for noticeable share of global Echocardiography Market and is projected to experience significant growth in the near future.

The Transthoracic Echocardiography segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies FUJIFILM Holdings Corporation , Boston Scientific Corporation and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)